ReviewExperimental hematology & oncology2025
Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy.
Yong Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it